Phase III trial comparing two dose levels of epirubicin combined with cyclophosphamide with cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer. (Record no. 11338724)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02367 a2200649 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250514002253.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 200107s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 0732-183X |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1200/JCO.2001.19.12.3103 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Piccart, M J |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20010705 |
| 245 00 - TITLE STATEMENT | |
| Title | Phase III trial comparing two dose levels of epirubicin combined with cyclophosphamide with cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology |
| Date of publication, distribution, etc. | Jun 2001 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 3103-10 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Clinical Trial; Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Adult |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antineoplastic Combined Chemotherapy Protocols |
| General subdivision | adverse effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Belgium |
| General subdivision | epidemiology |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Breast Neoplasms |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Chemotherapy, Adjuvant |
| General subdivision | methods |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Cyclophosphamide |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Disease-Free Survival |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Dose-Response Relationship, Drug |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Epirubicin |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Female |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Fluorouracil |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Methotrexate |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Middle Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Prognosis |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Proportional Hazards Models |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Statistics, Nonparametric |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Survival Rate |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Di Leo, A |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Beauduin, M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Vindevoghel, A |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Michel, J |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Focan, C |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Tagnon, A |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Ries, F |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Gobert, P |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Finet, C |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Closon-Dejardin, M T |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Dufrane, J P |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Kerger, J |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Liebens, F |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Beauvois, S |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Bartholomeus, S |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Dolci, S |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Lobelle, J P |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Paesmans, M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Nogaret, J M |
| 773 0# - HOST ITEM ENTRY | |
| Title | Journal of clinical oncology : official journal of the American Society of Clinical Oncology |
| Related parts | vol. 19 |
| -- | no. 12 |
| -- | p. 3103-10 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1200/JCO.2001.19.12.3103">https://doi.org/10.1200/JCO.2001.19.12.3103</a> |
| Public note | Available from publisher's website |
No items available.